Thursday, December 29, 2022

Congressional Investigation into Alzheimer’s Drug Aduhelm Faults the F.D.A. and Biogen

The report said the F.D.A.’s approval process for Aduhelm was “rife with irregularities” and criticized Biogen for setting an “unjustifiably high price.”

from NYT > Top Stories https://ift.tt/jYOPTCi
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

I Have Some Questions for the Democrats Who Want to Run California

The Opinion columnist Ezra Klein moderates a forum with five of the top Democratic candidates for governor of California. from NYT > To...